2-es típusú cukorbetegség: vizsgálatok itt: Olaszország
53 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Acquaviva delle Fonti, Ancona, Bergamo, Brescia, Catania, Catanzaro, Chieti, Cosenza, Ferrara, Florence, L'aquila, Milan, Monza, Naples, Palermo, Pavia, Pisa, Rivoli, Rome, Savona, Trieste, Turin, Varese
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisNot yet taking people in OlaszországAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Acquaviva delle Fonti, Bari, Florence, Milan, Parma, Perugia, Ravenna, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - No phaseTaking peopleType 2 Diabetes, Obesity and Cortisol Excess
- Where
- Milan, Roma, Siena, Udine
- Életkor
- 18 év to 75 év
- People
- 3200
- Run by
- Istituto Auxologico Italiano
See details and how to joinNCT05759637 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Bari, Bergamo, Bologna, Catanzaro, Palermo, Perugia, Pisa, Rome, San Donato Milanese
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Bari, Bergamo, Bologna, Catanzaro, Milan, Palermo, Perugia, Rome
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - No phaseTaking peopleReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Ancona, Palermo, Verona
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Bologna, Chieti Scalo, Palermo, Rome, Sesto San Giovanni
- Életkor
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Ancona, Florence, Genoa, Messina, Milan, Naples, Verona
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 3. fázisNot yet taking people in OlaszországA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Arezzo, Bologna, Chieti Scalo, Florence, Milan, Modena, Naples, Padova, Parma, Pisa, Rome, Rozzano, Siena, A.O.U. Policlinico Paolo Giaccone, Osepdale Civile Fr 5, ASL Città di Torino
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - No phaseTaking peopleDifferentiating Heart Disease Between Adult-onset Autoimmune and Type 2 Diabetes
- Where
- Rome
- Életkor
- 30 év and over
- People
- 200
- Run by
- University of Roma La Sapienza
See details and how to joinNCT07911007 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bologna, Milan, Palermo, Pisa, Rome, Rozzano, Sesto San Giovanni, Turin
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peoplePhenotyping Patients With Type 2 Diabetes Mellitus and Cancer
- Where
- Novara
- Életkor
- 18 év and over
- People
- 779
- Run by
- Azienda Ospedaliero Universitaria Maggiore della Carita
See details and how to joinNCT06299800 - No phaseTaking peopleInvestigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity
- Where
- Novara
- Életkor
- 18 év and over
- People
- 195
- Run by
- Azienda Ospedaliero Universitaria Maggiore della Carita
See details and how to joinNCT06438900 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Bari, Bologna, Chieti, Milan, Modena, Naples, Rome
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - 3. fázisTaking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- Milan
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna, Roma, San Donato
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleCOLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
- Where
- Acquaviva delle Fonti, Ancona, Bagno A Ripoli, Campobasso, Chieti Scalo, Ferrara, Florence, Foggia, Genoa, La Spezia, Milan, Pisa, Pistoia, Ravenna, Turin
- Életkor
- 55 év to 80 év
- People
- 10 000 worldwide
- Run by
- Montreal Heart Institute
See details and how to joinNCT05633810 · EU 2024-516646-19-00 - 3. fázisTaking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Ancona, Bologna, Brescia, Catanzaro, Genoa, Messina, Milan, Perugia, Pisa
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - No phaseCsak meghívásosA Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
- Where
- Bolzano, Catania, Città di Castello, Cuneo, Marano Di Napoli (NA), Milan, Montoro, Padova, Pescara, Province of Macerata, Rome, San Giovanni in Fiore (CS)
- Életkor
- 18 év and over
- People
- 214
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07632404 - No phaseTaking peopleDevelopment of Smart Food /Nutraceutical Solutions Dedicated to Cardiometabolic Disorders in Ageing
- Where
- Novara
- Életkor
- 65 év and over
- People
- 15
- Run by
- Azienda Ospedaliero Universitaria Maggiore della Carita
See details and how to joinNCT07817290 - No phaseTaking peopleSusceptibility to Infectious Diseases in Obesity
- Where
- Novara
- Életkor
- 18 év to 65 év
- People
- 80
- Run by
- Azienda Ospedaliero Universitaria Maggiore della Carita
See details and how to joinNCT05975541 - 3. fázisTaking peopleA trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
- Where
- Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna, Rome, San Donato Milanese
- Életkor
- 18 év and over
- People
- 1010 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-524688-19-00 - 3. fázisNot yet taking people in OlaszországStudy of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
- Where
- Ascoli Piceno, Catanzaro, Milan, Parma, Rome, Verona
- Életkor
- 18 év and over
- People
- 760 worldwide
- Run by
- Tecnimede-Sociedade Tecnico-Medicinal S.A.
See details and how to join2025-524606-15-00 - No phaseTaking peopleEffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients
- Where
- Milan
- Életkor
- 18 év and over
- People
- 105
- Run by
- Fondazione Don Carlo Gnocchi ETS
See details and how to joinNCT05987410 - No phaseTaking peopleClinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients
- Where
- Rome
- Életkor
- 18 év and over
- People
- 579
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07608055